An investigation on cervical cancer and human papillomavirus vaccine knowledge, and analysis of influencing factors for choosing domestic or imported 2vHPV vaccine among females in Shenzhen, China

• Hauptverfasser: Linxiang Chen (Verfasst von), Fangfang Lu (Verfasst von), Ziqi Wang (Verfasst von), Hanqing Chen (Verfasst von), Mianling Chen (Verfasst von), Chunmiao Peng (Verfasst von), Kangming Chen (Verfasst von), Cuili Chen (Verfasst von), Huawei Xiong (Verfasst von), Xu Xie (Verfasst von)
• Format: Buch
• Veröffentlicht: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

In 2020, the domestic (Chinese native) 2v human papillomavirus (HPV) vaccine was approved for use in females. At present, there are obvious differences in demand for different HPV vaccines. We aimed to investigate knowledge level of cervical cancer and HPV vaccine and its influencing factors among t...